Can-Fite BioPharma Ltd.
CANF
$3.39
$0.030.89%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.48M | -2.48M | -2.44M | -2.44M | -1.96M |
| Total Depreciation and Amortization | 500.00 | 500.00 | 11.50K | 11.50K | 3.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.00K | 50.00K | 161.00K | 161.00K | 66.50K |
| Change in Net Operating Assets | 327.00K | 327.00K | -110.50K | -110.50K | 91.50K |
| Cash from Operations | -2.10M | -2.10M | -2.38M | -2.38M | -1.80M |
| Capital Expenditure | -500.00 | -500.00 | -500.00 | -500.00 | -500.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.50M | -1.50M | 1.50M | 1.50M | -1.50M |
| Cash from Investing | -1.50M | -1.50M | 1.50M | 1.50M | -1.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.14M | 3.14M | 1.69M | 1.69M | 3.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -256.00K |
| Cash from Financing | 3.14M | 3.14M | 1.69M | 1.69M | 3.36M |
| Foreign Exchange rate Adjustments | 500.00 | 500.00 | 4.50K | 4.50K | -1.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -463.00K | -463.00K | 814.50K | 814.50K | 53.00K |